Correlation Between Cardio Diagnostics and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Ikena Oncology, you can compare the effects of market volatilities on Cardio Diagnostics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Ikena Oncology.
Diversification Opportunities for Cardio Diagnostics and Ikena Oncology
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cardio and Ikena is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Ikena Oncology go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Ikena Oncology
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Ikena Oncology. In addition to that, Cardio Diagnostics is 4.33 times more volatile than Ikena Oncology. It trades about -0.05 of its total potential returns per unit of risk. Ikena Oncology is currently generating about 0.0 per unit of volatility. If you would invest 175.00 in Ikena Oncology on September 5, 2024 and sell it today you would lose (5.00) from holding Ikena Oncology or give up 2.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Ikena Oncology
Performance |
| Timeline |
| Cardio Diagnostics |
| Ikena Oncology |
Cardio Diagnostics and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Ikena Oncology
The main advantage of trading using opposite Cardio Diagnostics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| Ikena Oncology vs. Candel Therapeutics | Ikena Oncology vs. Cingulate Warrants | Ikena Oncology vs. Unicycive Therapeutics | Ikena Oncology vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |